Figure 1 | Scientific Reports

Figure 1

From: Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic aid

Figure 1

Effect of the immunomodulator on the survival of puppies affected by CPE. Puppies were daily administered with 0.5 mg of the immunomodulator showed an increase in survival (%) vs CT + V group. The initial number of puppies in the CT + V group was 7, and 4 died. The initial number of puppies in the CT + I group was 11, and only 2 died. The difference in survival percentage was 39.0%. Kaplan–Meier test and Gehan-Breslow-Wilcoxon post-hoc test were carried out. *P ≤ 0.05. CT conventional treatment, I immunomodulatory, V vehicle.

Back to article page